Raras
Buscar doenças, sintomas, genes...
Alteração do metabolismo da porfirina e do heme
ORPHA:309813DOENÇA RARA

Uma doença metabólica hereditária que surge de um problema no processo de como o corpo lida com as substâncias chamadas porfirinas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença metabólica hereditária que surge de um problema no processo de como o corpo lida com as substâncias chamadas porfirinas.

Medicamentos
7 registrados
AFAMELANOTIDE, DERSIMELAGON, GIVOSIRAN

Tem tratamento?

7 medicamentos registrados
Ver detalhes, fases e interações →
AFAMELANOTIDEDERSIMELAGONGIVOSIRANODEVIXIBATMARALIXIBATBITOPERTINCIMETIDINE
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
40 sintomas
🫘
Rins
31 sintomas
🧠
Neurológico
29 sintomas
🧬
Pele e cabelo
23 sintomas
🩸
Sangue
23 sintomas
🦴
Ossos e articulações
13 sintomas

+ 166 sintomas em outras categorias

Características mais comuns

Má absorção de gordura
Porfirinúria
Cicatrizes
Insônia
Concentração elevada de uroporfirina circulante
Vesícula cutânea
374sintomas
Sem dados (374)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 374 características clínicas mais associadas, ordenadas por frequência.

Má absorção de gorduraFat malabsorption
PorfirinúriaPorphyrinuria
CicatrizesScarring
InsôniaInsomnia
Concentração elevada de uroporfirina circulanteElevated circulating uroporphyrin concentration

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa2
Últimos 10 anos200publicações
Pico202598 papers
Linha do tempo
2024Hoje · 2026🧪 1987Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

31 genes identificados com associação a esta condição.

UTP4U3 small nucleolar RNA-associated protein 4 homologCandidate gene tested inTolerante
FUNÇÃO

Ribosome biogenesis factor. Involved in nucleolar processing of pre-18S ribosomal RNA. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted d Involved in SSU pre-rRNA proce

LOCALIZAÇÃO

Nucleus, nucleolusChromosome

VIAS BIOLÓGICAS (2)
rRNA modification in the nucleus and cytosolMajor pathway of rRNA processing in the nucleolus and cytosol
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
34.4 TPM
Testículo
33.7 TPM
Fibroblastos
31.4 TPM
Músculo esquelético
21.0 TPM
Útero
18.4 TPM
OUTRAS DOENÇAS (1)
hereditary North American Indian childhood cirrhosis
HGNC:1983UniProt:Q969X6
SLCO1B3Solute carrier organic anion transporter family member 1B3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Mediates the Na(+)-independent uptake of organic anions (PubMed:10779507, PubMed:15159445, PubMed:17412826). Shows broad substrate specificity, can transport both organic anions such as bile acid taurocholate (cholyltaurine) and conjugated steroids (17-beta-glucuronosyl estradiol, dehydroepiandrosterone sulfate (DHEAS), and estrone 3-sulfate), as well as eicosanoid leukotriene C4, prostaglandin E2 and L-thyroxine (T4) (PubMed:10779507, PubMed:11159893, PubMed:12568656, PubMed:15159445, PubMed:17

LOCALIZAÇÃO

Basolateral cell membraneBasal cell membrane

VIAS BIOLÓGICAS (4)
Heme degradationAtorvastatin ADMERecycling of bile acids and saltsOrganic anion transport by SLCO transporters
MECANISMO DE DOENÇA

Hyperbilirubinemia, Rotor type

An autosomal recessive form of primary conjugated hyperbilirubinemia. Affected individuals develop mild jaundice not associated with hemolysis shortly after birth or in childhood. They have delayed plasma clearance of the unconjugated anionic dye bromsulphthalein and prominent urinary excretion of coproporphyrin I. Hepatic pigmentation is normal.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
41.3 TPM
Nervo tibial
2.6 TPM
Testículo
1.4 TPM
Glândula salivar
0.7 TPM
Cervix Endocervix
0.6 TPM
OUTRAS DOENÇAS (1)
Rotor syndrome
HGNC:10961UniProt:Q9NPD5
UROSUroporphyrinogen-III synthaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes cyclization of the linear tetrapyrrole, hydroxymethylbilane, to the macrocyclic uroporphyrinogen III, the branch point for the various sub-pathways leading to the wide diversity of porphyrins (PubMed:11689424, PubMed:18004775). Porphyrins act as cofactors for a multitude of enzymes that perform a variety of processes within the cell such as methionine synthesis (vitamin B12) or oxygen transport (heme) (PubMed:11689424, PubMed:18004775)

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Congenital erythropoietic porphyria

Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. The manifestations of CEP are heterogeneous, ranging from nonimmune hydrops fetalis due to severe hemolytic anemia in utero to milder, later onset forms, which have only skin lesions due to cutaneous photosensitivity in adult life. The deficiency in UROS activity results in the non-enzymatic conversion of hydroxymethylbilane (HMB) into the uroporphyrinogen-I isomer.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
24.6 TPM
Córtex cerebral
23.3 TPM
Brain Frontal Cortex BA9
22.9 TPM
Brain Caudate basal ganglia
22.0 TPM
Cérebro - Amígdala
21.3 TPM
OUTRAS DOENÇAS (1)
cutaneous porphyria
HGNC:12592UniProt:P10746
SLC51AOrganic solute transporter subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood (PubMed:16317684). Efficiently transports the major species of bile acids (taurocholate) (PubMed:16317684). Taurine conjugates are transported more efficiently across the basolateral membrane than glycine-conjugated bile acids (By similarity). Can also transport steroids such as estrone 3-sulfate and dehydroep

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Recycling of bile acids and salts
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 6

An autosomal recessive form of progressive cholestasis, a disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease. PFIC6 patients have elevated liver transaminases and congenital diarrhea.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
18.9 TPM
Intestino delgado
17.6 TPM
Testículo
9.8 TPM
Glândula adrenal
5.3 TPM
Sangue
4.3 TPM
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 6
HGNC:HGNC:29955UniProt:Q86UW1
ZFYVE19Abscission/NoCut checkpoint regulatorDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key regulator of abscission step in cytokinesis: part of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage. Together with CHMP4C, required to retain abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosomeCleavage furrowMidbody, Midbody ring

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
29.0 TPM
Cervix Endocervix
27.0 TPM
Cérebro - Hemisfério cerebelar
24.8 TPM
Próstata
24.4 TPM
Nervo tibial
23.6 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 9
HGNC:HGNC:20758UniProt:Q96K21
ABCC2ATP-binding cassette sub-family C member 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

ATP-dependent transporter of the ATP-binding cassette (ABC) family that binds and hydrolyzes ATP to enable active transport of various substrates including many drugs, toxicants and endogenous compound across cell membranes. Transports a wide variety of conjugated organic anions such as sulfate-, glucuronide- and glutathione (GSH)-conjugates of endo- and xenobiotics substrates (PubMed:10220572, PubMed:10421658, PubMed:11500505, PubMed:16332456). Mediates hepatobiliary excretion of mono- and bis-

LOCALIZAÇÃO

Apical cell membrane

VIAS BIOLÓGICAS (5)
Heme degradationABC-family proteins mediated transportParacetamol ADMEAspirin ADMEAtorvastatin ADME
MECANISMO DE DOENÇA

Dubin-Johnson syndrome

Autosomal recessive disorder characterized by conjugated hyperbilirubinemia, an increase in the urinary excretion of coproporphyrin isomer I, deposition of melanin-like pigment in hepatocytes, and prolonged retention of sulfobromophthalein, but otherwise normal liver function.

OUTRAS DOENÇAS (1)
Dubin-Johnson syndrome
HGNC:53UniProt:Q92887
HMOX1Heme oxygenase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the oxidative cleavage of heme at the alpha-methene bridge carbon, released as carbon monoxide (CO), to generate biliverdin IXalpha, while releasing the central heme iron chelate as ferrous iron (PubMed:11121422, PubMed:19556236, PubMed:7703255). Affords protection against programmed cell death and this cytoprotective effect relies on its ability to catabolize free heme and prevent it from sensitizing cells to undergo apoptosis (PubMed:20055707) (Microbial infection) During SARS-COV-2

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (8)
Cytoprotection by HMOX1Heme degradationIron uptake and transportRegulation of HMOX1 expression and activityHeme signaling
MECANISMO DE DOENÇA

Heme oxygenase 1 deficiency

A disease characterized by impaired stress hematopoiesis, resulting in marked erythrocyte fragmentation and intravascular hemolysis, coagulation abnormalities, endothelial damage, and iron deposition in renal and hepatic tissues. Clinical features include persistent hemolytic anemia, asplenia, nephritis, generalized erythematous rash, growth retardation and hepatomegaly.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
895.4 TPM
Fibroblastos
185.9 TPM
Ovário
153.0 TPM
Pulmão
133.0 TPM
Skin Sun Exposed Lower leg
110.7 TPM
OUTRAS DOENÇAS (3)
heme oxygenase 1 deficiencycystic fibrosischronic obstructive pulmonary disease
HGNC:5013UniProt:P09601
ABCB11Bile salt export pumpDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transport of the major hydrophobic bile salts, such as taurine and glycine-conjugated cholic acid across the canalicular membrane of hepatocytes in an ATP-dependent manner, therefore participates in hepatic bile acid homeostasis and consequently to lipid homeostasis through regulation of biliary lipid secretion in a bile salts dependent manner (PubMed:15791618, PubMed:16332456, PubMed:18985798, PubMed:19228692, PubMed:20010382, PubMed:20398791, PubMed:22262466, PubMed:24711118, Pub

LOCALIZAÇÃO

Apical cell membraneRecycling endosome membraneEndosomeCell membrane

VIAS BIOLÓGICAS (2)
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterolRecycling of bile acids and salts
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 2

A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. PFIC2 inheritance is autosomal recessive.

OUTRAS DOENÇAS (3)
progressive familial intrahepatic cholestasis type 2benign recurrent intrahepatic cholestasis type 2intrahepatic cholestasis of pregnancy
HGNC:42UniProt:O95342
USP53Ubiquitin carboxyl-terminal hydrolase 53Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Deubiquitinase that mediates 'Lys-63'-linked deubiquitination of tight junction proteins, such as MARVELD2 and LSR, and which is involved in the survival of auditory hair cells and hearing (PubMed:32124521, PubMed:39587316). Specifically cleaves 'Lys-63'-linked polyubiquitin chains composed of at least 3 ubiquitin molecules, while it is not able to deubiquitinate substrates with shorter ubiquitin chains: recognizes ubiquitin chain in position S2 and catalyzes en bloc cleavage of polyubiquitin ch

LOCALIZAÇÃO

Cell junction, tight junction

MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 7, with or without hearing loss

An autosomal recessive form of progressive cholestasis, a disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease. Some PFIC7 patients develop hearing loss in childhood.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
202.8 TPM
Fibroblastos
63.9 TPM
Pulmão
58.7 TPM
Tecido adiposo
47.6 TPM
Aorta
45.8 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 7, with or without hearing loss
HGNC:HGNC:29255UniProt:Q70EK8
HMBSPorphobilinogen deaminaseDisease-causing germline mutation(s) inRestrito
FUNÇÃO

As part of the heme biosynthetic pathway, catalyzes the sequential polymerization of four molecules of porphobilinogen to form hydroxymethylbilane, also known as preuroporphyrinogen (PubMed:18004775, PubMed:18936296, PubMed:19138865, PubMed:23815679). Catalysis begins with the assembly of the dipyrromethane cofactor by the apoenzyme from two molecules of porphobilinogen or from preuroporphyrinogen. The covalently linked cofactor acts as a primer, around which the tetrapyrrole product is assemble

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Acute intermittent porphyria

A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AIP is an autosomal dominant form of hepatic porphyria characterized by attacks of gastrointestinal disturbances, abdominal colic, with neurological dysfunctions, hypertension, tachycardia and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
26.1 TPM
Fibroblastos
22.1 TPM
Sangue
15.6 TPM
Baço
15.2 TPM
Tireoide
14.1 TPM
OUTRAS DOENÇAS (3)
leukoencephalopathy, porphyria-relatedacute intermittent porphyriaencephalopathy, porphyria-related
HGNC:4982UniProt:P08397
PPOXProtoporphyrinogen oxidaseDisease-causing germline mutation(s) inModerado
FUNÇÃO

Catalyzes the 6-electron oxidation of protoporphyrinogen-IX to form protoporphyrin-IX

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Variegate porphyria

A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Variegate porphyria is an acute hepatic form characterized by partial reduction of protoporphyrinogen oxidase activity, increased photosensitivity, skin blistering and scarring of sun-exposed areas, skin hyperpigmentation, abdominal pain, and neuropsychiatric symptoms. High fecal levels of protoporphyrin and coproporphyrin, increased urine uroporphyrins and iron overload are typical markers of the disease. Inheritance is autosomal dominant with incomplete penetrance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Endocervix
40.6 TPM
Ovário
35.9 TPM
Útero
34.6 TPM
Tireoide
34.6 TPM
Pituitária
33.3 TPM
OUTRAS DOENÇAS (2)
variegate porphyria, childhood-onsetvariegate porphyria
HGNC:9280UniProt:P50336
PSKH1Serine/threonine-protein kinase H1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Serine/threonine protein kinase that may be involved in the regulation of pre-mRNA processing. It may phosphorylate components of nuclear splice factor compartments (SFC), such as non-snRNP splicing factors containing a serine/arginine-rich domain (SR proteins). Reversible phosphorylation of SR proteins may cause their release into the nucleoplasm and change their local concentration, thereby influencing alternative splicing

LOCALIZAÇÃO

Golgi apparatusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeNucleus speckleEndoplasmic reticulum membraneCell membraneCytoplasm

MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 13

A form of progressive cholestasis, a disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease. PFIC13 is an autosomal recessive form characterized by progressive liver dysfunction and chronic renal failure often associated with unilateral renal agenesis and glomerulosclerosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
46.0 TPM
Útero
37.3 TPM
Ovário
34.7 TPM
Fallopian Tube
34.5 TPM
Esôfago - Junção
33.3 TPM
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 13
HGNC:HGNC:9529UniProt:P11801
MYO5BUnconventional myosin-VbDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May be involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation. Required in a complex with RAB11A and RAB11FIP2 for the transport of NPC1L1 to the plasma membrane. Together with RAB11A participates in CFTR trafficking to the plasma membrane and TF (transferrin) recycling in nonpolarized cells. Together with RAB11A and RAB8A participates in epithelial cell polarization. Tog

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Vasopressin regulates renal water homeostasis via Aquaporins
MECANISMO DE DOENÇA

Diarrhea 2, with microvillus atrophy, with or without cholestasis

A disease characterized by onset of intractable life-threatening watery diarrhea during infancy. Two forms are recognized: early-onset microvillus inclusion disease with diarrhea beginning in the neonatal period, and late-onset, with first symptoms appearing after 3 or 4 months of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
20.9 TPM
Tireoide
20.5 TPM
Skin Sun Exposed Lower leg
20.1 TPM
Glândula salivar
18.1 TPM
Vagina
18.0 TPM
OUTRAS DOENÇAS (4)
microvillus inclusion diseasecholestasis, progressive familial intrahepatic, 10MYO5B-related progressive familial intrahepatic cholestasisprogressive familial intrahepatic cholestasis type 1
HGNC:7603UniProt:Q9ULV0
SEMA7ASemaphorin-7ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays an important role in integrin-mediated signaling and functions both in regulating cell migration and immune responses. Promotes formation of focal adhesion complexes, activation of the protein kinase PTK2/FAK1 and subsequent phosphorylation of MAPK1 and MAPK3. Promotes production of pro-inflammatory cytokines by monocytes and macrophages. Plays an important role in modulating inflammation and T-cell-mediated immune responses. Promotes axon growth in the embryonic olfactory bulb. Promotes a

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Other semaphorin interactions
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 11

An autosomal recessive form of progressive cholestasis, a disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
236.5 TPM
Baço
90.0 TPM
Brain Spinal cord cervical c-1
67.1 TPM
Cerebelo
58.8 TPM
Testículo
57.1 TPM
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 11
HGNC:HGNC:10741UniProt:O75326
TJP2Tight junction protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a role in tight junctions and adherens junctions (By similarity). Acts as a positive regulator of RANKL-induced osteoclast differentiation, potentially via mediating downstream transcriptional activity (By similarity)

LOCALIZAÇÃO

Cell junction, adherens junctionCell membraneCell junction, tight junctionNucleus

VIAS BIOLÓGICAS (1)
Signaling by Hippo
MECANISMO DE DOENÇA

Hypercholanemia, familial, 1

A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
103.6 TPM
Nervo tibial
85.5 TPM
Pulmão
84.2 TPM
Tecido adiposo
81.3 TPM
Tireoide
80.0 TPM
OUTRAS DOENÇAS (3)
cholestasis, progressive familial intrahepatic, 4hypercholanemia, familial 1autosomal dominant nonsyndromic hearing loss
HGNC:11828UniProt:Q9UDY2
ALADDelta-aminolevulinic acid dehydrataseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes an early step in the biosynthesis of tetrapyrroles. Binds two molecules of 5-aminolevulinate per subunit, each at a distinct site, and catalyzes their condensation to form porphobilinogen

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Acute hepatic porphyria

A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. AHP is characterized by attacks of gastrointestinal disturbances, abdominal colic, paralyses and peripheral neuropathy. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors.

OUTRAS DOENÇAS (1)
porphyria due to ALA dehydratase deficiency
HGNC:395UniProt:P13716
GATA1Erythroid transcription factorCandidate gene tested inAltamente restrito
FUNÇÃO

Transcriptional activator or repressor which serves as a general switch factor for erythroid development (PubMed:35030251). It binds to DNA sites with the consensus sequence 5'-[AT]GATA[AG]-3' within regulatory regions of globin genes and of other genes expressed in erythroid cells. Activates the transcription of genes involved in erythroid differentiation of K562 erythroleukemia cells, including HBB, HBG1/2, ALAS2 and HMBS (PubMed:24245781)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet functionRUNX1 regulates transcription of genes involved in differentiation of HSCsFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

X-linked dyserythropoietic anemia and thrombocytopenia

Disorder characterized by erythrocytes with abnormal size and shape, and paucity of platelets in peripheral blood. The bone marrow contains abundant and abnormally small megakaryocytes.

EXPRESSÃO TECIDUAL(Tecido-específico)
Sangue
25.8 TPM
Pulmão
3.7 TPM
Testículo
3.6 TPM
Baço
1.9 TPM
Pituitária
0.8 TPM
OUTRAS DOENÇAS (10)
transient myeloproliferative syndromethrombocytopenia, X-linked, with or without dyserythropoietic anemiahemolytic anemia due to erythrocyte adenosine deaminase overproductionX-linked dyserythropoetic anemia with abnormal platelets and neutropenia
HGNC:4170UniProt:P15976
NR1H4Bile acid receptorDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Ligand-activated transcription factor. Receptor for bile acids (BAs) such as chenodeoxycholic acid (CDCA), lithocholic acid, deoxycholic acid (DCA) and allocholic acid (ACA). Plays a essential role in BA homeostasis through the regulation of genes involved in BA synthesis, conjugation and enterohepatic circulation. Also regulates lipid and glucose homeostasis and is involved innate immune response (PubMed:10334992, PubMed:10334993, PubMed:21383957, PubMed:22820415). The FXR-RXR heterodimer binds

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (6)
Recycling of bile acids and saltsSynthesis of bile acids and bile saltsEndogenous sterolsSynthesis of bile acids and bile salts via 7alpha-hydroxycholesterolSynthesis of bile acids and bile salts via 27-hydroxycholesterol
EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
39.1 TPM
Glândula adrenal
22.9 TPM
Intestino delgado
21.5 TPM
Ovário
12.9 TPM
Rim - Medula
11.2 TPM
OUTRAS DOENÇAS (2)
cholestasis, progressive familial intrahepatic, 5intrahepatic cholestasis of pregnancy
HGNC:7967UniProt:Q96RI1
VIPAS39Spermatogenesis-defective protein 39 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Proposed to be involved in endosomal maturation implicating in part VPS33B. In epithelial cells, the VPS33B:VIPAS39 complex may play a role in the apical RAB11A-dependent recycling pathway and in the maintenance of the apical-basolateral polarity (PubMed:20190753). May play a role in lysosomal trafficking, probably via association with the core HOPS complex in a discrete population of endosomes; the functions seems to be independent of VPS33B (PubMed:19109425). May play a role in vesicular traff

LOCALIZAÇÃO

CytoplasmCytoplasmic vesicleEarly endosomeRecycling endosomeLate endosome

MECANISMO DE DOENÇA

Arthrogryposis, renal dysfunction and cholestasis syndrome 2

A multisystem disorder, characterized by neurogenic arthrogryposis multiplex congenita, renal tubular dysfunction and neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity. Platelet dysfunction is common.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
30.7 TPM
Testículo
29.8 TPM
Ovário
27.4 TPM
Artéria tibial
25.9 TPM
Nervo tibial
25.3 TPM
OUTRAS DOENÇAS (2)
arthrogryposis, renal dysfunction, and cholestasis 2arthrogryposis-renal dysfunction-cholestasis syndrome
HGNC:20347UniProt:Q9H9C1
UGT1A1UDP-glucuronosyltransferase 1A1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile (PubMed:12181437, PubMed:15472229, PubMed:18004206, PubMed:18004212, PubMed:18719240, PubMed:19830808, PubMed:23288867, PubMed:15231852, PubMed:21422672, PubMed:38211441). Essential for the elimination and detoxification of drugs, xenobiot

LOCALIZAÇÃO

Endoplasmic reticulum membraneCytoplasm, perinuclear region

VIAS BIOLÓGICAS (4)
GlucuronidationHeme degradationAspirin ADMEParacetamol ADME
MECANISMO DE DOENÇA

Gilbert syndrome

Occurs as a consequence of reduced bilirubin transferase activity and is often detected in young adults with vague non-specific complaints.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
22.6 TPM
Esôfago - Mucosa
4.2 TPM
Intestino delgado
2.3 TPM
Rim - Córtex
2.2 TPM
Cólon transverso
1.4 TPM
OUTRAS DOENÇAS (5)
Gilbert syndromeobsolete bilirubin, serum level of, quantitative trait locus 1Crigler-Najjar syndrome type 2transient familial neonatal hyperbilirubinemia
HGNC:12530UniProt:P22309
HFEHereditary hemochromatosis proteinCandidate gene tested inTolerante
FUNÇÃO

Binds to transferrin receptor (TFR) and reduces its affinity for iron-loaded transferrin

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
Transferrin endocytosis and recycling
MECANISMO DE DOENÇA

Hemochromatosis 1

A disorder of iron metabolism characterized by iron overload. Excess iron is deposited in a variety of organs leading to their failure, and resulting in serious illnesses including cirrhosis, hepatomas, diabetes, cardiomyopathy, arthritis, and hypogonadotropic hypogonadism. Severe effects of the disease usually do not appear until after decades of progressive iron loading.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
15.7 TPM
Glândula adrenal
8.8 TPM
Baço
7.8 TPM
Aorta
6.6 TPM
Cervix Endocervix
6.5 TPM
OUTRAS DOENÇAS (6)
hemochromatosis type 1sporadic porphyria cutanea tardafamilial porphyria cutanea tardaobsolete symptomatic form of hemochromatosis type 1
HGNC:4886UniProt:Q30201
ATP8B1Phospholipid-transporting ATPase ICDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of phospholipids, in particular phosphatidylcholines (PC), from the outer to the inner leaflet of the plasma membrane (PubMed:17948906, PubMed:25315773). May participate in the establishment of the canalicular membrane integrity by ensuring asymmetric distribution of phospholipids in the canicular membrane (By similarity). Thus may have a role in the regulation of bile acids transpo

LOCALIZAÇÃO

Cell membraneApical cell membraneCell projection, stereociliumEndoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (1)
Ion transport by P-type ATPases
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 1

A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. PFIC1 inheritance is autosomal recessive.

OUTRAS DOENÇAS (4)
cholestasis, intrahepatic, of pregnancy, 1progressive familial intrahepatic cholestasis type 1benign recurrent intrahepatic cholestasis type 1intrahepatic cholestasis of pregnancy
HGNC:3706UniProt:O43520
CLPXATP-dependent clpX-like chaperone, mitochondrialDisease-causing germline mutation(s) inRestrito
FUNÇÃO

ATP-dependent chaperone that functions as an unfoldase. As part of the ClpXP protease complex, it recognizes specific protein substrates, unfolds them using energy derived from ATP hydrolysis, and then translocates them to the proteolytic subunit (CLPP) of the ClpXP complex for degradation (PubMed:11923310, PubMed:22710082, PubMed:28874591). Thanks to its chaperone activity, it also functions in the incorporation of the pyridoxal phosphate cofactor into 5-aminolevulinate synthase, thereby activa

LOCALIZAÇÃO

MitochondrionMitochondrion matrix, mitochondrion nucleoid

VIAS BIOLÓGICAS (1)
Mitochondrial protein degradation
MECANISMO DE DOENÇA

Protoporphyria, erythropoietic, 2

An autosomal dominant form of porphyria with onset in infancy. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Erythropoietic protoporphyria is marked by excessive protoporphyrin in erythrocytes, plasma, liver and feces, and by widely varying photosensitive skin changes ranging from a burning or pruritic sensation to erythema, edema and wheals.

OUTRAS DOENÇAS (1)
protoporphyria, erythropoietic, 2
HGNC:HGNC:2088UniProt:O76031
ABCB4Phosphatidylcholine translocator ABCB4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Energy-dependent phospholipid efflux translocator that acts as a positive regulator of biliary lipid secretion. Functions as a floppase that translocates specifically phosphatidylcholine (PC) from the inner to the outer leaflet of the canalicular membrane bilayer into the canaliculi of hepatocytes. Translocation of PC makes the biliary phospholipids available for extraction into the canaliculi lumen by bile salt mixed micelles and therefore protects the biliary tree from the detergent activity o

LOCALIZAÇÃO

Cell membraneApical cell membraneMembrane raftCytoplasmCytoplasmic vesicle, clathrin-coated vesicle

VIAS BIOLÓGICAS (2)
ABC-family proteins mediated transportPPARA activates gene expression
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 3

A disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease before adulthood. PFIC3 inheritance is autosomal recessive.

OUTRAS DOENÇAS (4)
gallbladder disease 1progressive familial intrahepatic cholestasis type 3cholestasis, intrahepatic, of pregnancy, 3intrahepatic cholestasis of pregnancy
HGNC:45UniProt:P21439
SLCO1B1Solute carrier organic anion transporter family member 1B1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Mediates the Na(+)-independent uptake of organic anions (PubMed:10358072, PubMed:15159445, PubMed:17412826). Shows broad substrate specificity, can transport both organic anions such as bile acid taurocholate (cholyltaurine) and conjugated steroids (dehydroepiandrosterone 3-sulfate, 17-beta-glucuronosyl estradiol, and estrone 3-sulfate), as well as eicosanoids (prostaglandin E2, thromboxane B2, leukotriene C4, and leukotriene E4), and thyroid hormones (T4/L-thyroxine, and T3/3,3',5'-triiodo-L-th

LOCALIZAÇÃO

Basolateral cell membraneBasal cell membrane

VIAS BIOLÓGICAS (4)
Heme degradationAtorvastatin ADMERecycling of bile acids and saltsOrganic anion transport by SLCO transporters
MECANISMO DE DOENÇA

Hyperbilirubinemia, Rotor type

An autosomal recessive form of primary conjugated hyperbilirubinemia. Affected individuals develop mild jaundice not associated with hemolysis shortly after birth or in childhood. They have delayed plasma clearance of the unconjugated anionic dye bromsulphthalein and prominent urinary excretion of coproporphyrin I. Hepatic pigmentation is normal.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fígado
56.7 TPM
Testículo
0.2 TPM
Nervo tibial
0.1 TPM
Cervix Endocervix
0.0 TPM
Glândula salivar
0.0 TPM
OUTRAS DOENÇAS (1)
Rotor syndrome
HGNC:10959UniProt:Q9Y6L6
KIF12Kinesin-like protein KIF12Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the negative regulation of fatty acid biosynthesis, probably acting as an adapter that allows ubiquitination of acetyl-CoA carboxylase 1 (ACACA) by E3 ubiquitin-protein ligase COP1, and promotes ACACA degradation (PubMed:39920308). The adapter function requires the C-terminal proline-rich domain and may be apart from the kinesin motor activity (Probable)

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCell projection, cilium

VIAS BIOLÓGICAS (2)
KinesinsCOPI-dependent Golgi-to-ER retrograde traffic
MECANISMO DE DOENÇA

Cholestasis, progressive familial intrahepatic, 8

An autosomal recessive form of progressive cholestasis, a disorder characterized by early onset of cholestasis that progresses to hepatic fibrosis, cirrhosis, and end-stage liver disease. PFIC8 onset is in early infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Rim - Medula
243.8 TPM
Rim - Córtex
166.0 TPM
Tireoide
80.1 TPM
Pâncreas
69.7 TPM
Fígado
21.6 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
cholestasis, progressive familial intrahepatic, 8
HGNC:HGNC:21495UniProt:Q96FN5
URODUroporphyrinogen decarboxylaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the sequential decarboxylation of the four acetate side chains of uroporphyrinogen to form coproporphyrinogen and participates in the fifth step in the heme biosynthetic pathway (PubMed:11069625, PubMed:11719352, PubMed:14633982, PubMed:18004775, PubMed:21668429). Isomer I or isomer III of uroporphyrinogen may serve as substrate, but only coproporphyrinogen III can ultimately be converted to heme (PubMed:11069625, PubMed:11719352, PubMed:14633982, PubMed:21668429). In vitro also decarb

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Familial porphyria cutanea tarda

A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Familial porphyria cutanea tarda is an autosomal dominant disorder characterized by light-sensitive dermatitis, with onset in later life. It is associated with the excretion of large amounts of uroporphyrin in the urine. Iron overload is often present in association with varying degrees of liver damage.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
100.8 TPM
Fibroblastos
74.4 TPM
Útero
72.0 TPM
Tireoide
69.1 TPM
Ovário
65.2 TPM
OUTRAS DOENÇAS (2)
familial porphyria cutanea tardahepatoerythropoietic porphyria
HGNC:12591UniProt:P06132
VPS33BVacuolar protein sorting-associated protein 33BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May play a role in vesicle-mediated protein trafficking to lysosomal compartments and in membrane docking/fusion reactions of late endosomes/lysosomes. Required for proper trafficking and targeting of the collagen-modifying enzyme lysyl hydroxylase 3 (LH3) to intracellular collagen (PubMed:28017832). Mediates phagolysosomal fusion in macrophages (PubMed:18474358). Proposed to be involved in endosomal maturation implicating VIPAS39. In epithelial cells, the VPS33B:VIPAS39 complex may play a role

LOCALIZAÇÃO

Late endosome membraneLysosome membraneEarly endosomeCytoplasmic vesicle, clathrin-coated vesicleRecycling endosome

VIAS BIOLÓGICAS (1)
SARS-CoV-2 modulates autophagy
MECANISMO DE DOENÇA

Arthrogryposis, renal dysfunction, and cholestasis 1

An autosomal recessive multisystem disorder with characteristics of congenital joint contractures, renal tubular dysfunction, neonatal cholestasis with bile duct hypoplasia and low gamma glutamyl transpeptidase activity, severe failure to thrive, ichthyosis, and a defect in platelet alpha-granule biogenesis. Most patients do not survive past the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
34.6 TPM
Cerebelo
32.5 TPM
Linfócitos
31.3 TPM
Skin Sun Exposed Lower leg
27.8 TPM
Útero
24.4 TPM
OUTRAS DOENÇAS (4)
keratoderma-ichthyosis-deafness syndrome, autosomal recessivecholestasis, progressive familial intrahepatic, 12arthrogryposis, renal dysfunction, and cholestasis 1arthrogryposis-renal dysfunction-cholestasis syndrome
HGNC:12712UniProt:Q9H267
ALAS25-aminolevulinate synthase, erythroid-specific, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products (PubMed:14643893, PubMed:21252495, PubMed:21309041, PubMed:21653323, PubMed:32499479, PubMed:34492704). Contributes significantly to heme formation during erythropoiesis (PubMed:2050125) Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Anemia, sideroblastic, 1

A form of sideroblastic anemia that shows a variable hematologic response to pharmacologic doses of pyridoxine. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
X-linked erythropoietic protoporphyriaX-linked sideroblastic anemia 1
HGNC:397UniProt:P22557
FECHFerrochelatase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the ferrous insertion into protoporphyrin IX and participates in the terminal step in the heme biosynthetic pathway

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Heme biosynthesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Protoporphyria, erythropoietic, 1

An autosomal recessive form of porphyria with onset usually before age 10 years. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Erythropoietic protoporphyria is marked by excessive protoporphyrin in erythrocytes, plasma, liver and feces, and by widely varying photosensitive skin changes ranging from a burning or pruritic sensation to erythema, edema and wheals.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
22.7 TPM
Rim - Medula
21.6 TPM
Glândula adrenal
18.7 TPM
Linfócitos
18.6 TPM
Músculo esquelético
18.3 TPM
OUTRAS DOENÇAS (2)
protoporphyria, erythropoietic, 1autosomal erythropoietic protoporphyria
HGNC:3647UniProt:P22830
CPOXOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the aerobic oxidative decarboxylation of propionate groups of rings A and B of coproporphyrinogen-III to yield the vinyl groups in protoporphyrinogen-IX and participates to the sixth step in the heme biosynthetic pathway

LOCALIZAÇÃO

Mitochondrion intermembrane space

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Hereditary coproporphyria

A form of porphyria. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Hereditary coproporphyria is an acute hepatic porphyria characterized by skin photosensitivity, attacks of abdominal pain, neurological disturbances, and psychiatric symptoms. Most attacks are precipitated by drugs, alcohol, caloric deprivation, infections, or endocrine factors. Hereditary coproporphyria is biochemically characterized by overexcretion of coproporphyrin III in the urine and in the feces.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
hereditary coproporphyriaharderoporphyria
HGNC:2321UniProt:P36551

Medicamentos e terapias

AFAMELANOTIDEPhase 4

Mecanismo: Melanocortin receptor 1 agonist

DERSIMELAGONPhase 3

Mecanismo: Melanocortin receptor 1 agonist

GIVOSIRANPhase 3

Mecanismo: 5-aminolevulinate synthase mRNA RNAi inhibitor

ODEVIXIBATPhase 3

Mecanismo: Ileal bile acid transporter inhibitor

MARALIXIBATPhase 3

Mecanismo: Ileal bile acid transporter inhibitor

BITOPERTINPhase 2

Mecanismo: Glycine transporter 1 inhibitor

CIMETIDINEPhase 2

Mecanismo: Histamine H2 receptor antagonist

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

188 variantes patogênicas registradas no ClinVar.

🧬 UTP4: NM_032830.3(UTP4):c.1312C>T (p.Arg438Cys) ()
🧬 UTP4: NM_032830.3(UTP4):c.1834-11T>C ()
🧬 UTP4: NM_032830.3(UTP4):c.351+138A>G ()
🧬 UTP4: GRCh37/hg19 16q22.1(chr16:67538639-69583342)x1 ()
🧬 UTP4: GRCh37/hg19 16q22.1(chr16:67322830-69368947)x1 ()
Ver todas no ClinVar

Vias biológicas (Reactome)

51 vias biológicas associadas aos genes desta condição.

rRNA modification in the nucleus and cytosol Major pathway of rRNA processing in the nucleolus and cytosol Recycling of bile acids and salts Heme degradation Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR) Organic anion transport by SLCO transporters Atorvastatin ADME Heme biosynthesis ABC-family proteins mediated transport Defective ABCC2 causes DJS Aspirin ADME Paracetamol ADME Interleukin-4 and Interleukin-13 signaling The NLRP3 inflammasome Iron uptake and transport Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Purinergic signaling in leishmaniasis infection Cytoprotection by HMOX1 Regulation of HMOX1 expression and activity Heme signaling NFE2L2 regulating anti-oxidant/detoxification enzymes Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol Defective ABCB11 causes PFIC2 and BRIC2 Vasopressin regulates renal water homeostasis via Aquaporins Other semaphorin interactions Signaling by Hippo Apoptotic cleavage of cell adhesion proteins RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle Neutrophil degranulation RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function RUNX1 regulates transcription of genes involved in differentiation of HSCs Factors involved in megakaryocyte development and platelet production Synthesis of bile acids and bile salts Synthesis of bile acids and bile salts via 27-hydroxycholesterol PPARA activates gene expression Endogenous sterols Nuclear Receptor transcription pathway SUMOylation of intracellular receptors Glucuronidation Defective UGT1A1 causes hyperbilirubinemia Transferrin endocytosis and recycling Ion transport by P-type ATPases Mitochondrial protein degradation Defective ABCB4 causes PFIC3, ICP3 and GBD1 Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR) COPI-dependent Golgi-to-ER retrograde traffic Kinesins Prevention of phagosomal-lysosomal fusion SARS-CoV-2 modulates autophagy

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 34
2Fase 22
Medicamentos catalogadosEnsaios clínicos· 7 medicamentos · 0 ensaios
✓ Aprovados — podem ser usados hoje
AFAMELANOTIDE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Alteração do metabolismo da porfirina e do heme

Centros de Referência SUS

21 centros habilitados pelo SUS para Alteração do metabolismo da porfirina e do heme

Centros para Alteração do metabolismo da porfirina e do heme

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥉Melhor nível de evidência: Relato de caso
Timeline de publicações
0 papers (10 anos)
#1

Bafilomycin A1 is a promising therapeutic agent against T. spiralis infection by inhibiting the heme-transporting ATP6V0C/HRG-1 complex.

PLoS pathogens2026 Mar

Trichinella spiralis (T. spiralis), a zoonotic nematode that causes severe myositis and systemic morbidity, sustains chronic muscle parasitism through evolutionary adaptations; however, this globally prevalent disease lacks targeted therapies to disrupt chronic infection. Although the heme transport protein HRG-1 has been characterized as an intervention target in free-living species (e.g., Caenorhabditis elegans) and hematophagous parasites (e.g., Haemonchus contortus), the molecular machinery governing heme acquisition in the nonhematophagous parasite T. spiralis remains uncharacterized, and no drugs targeting HRG-1 have been reported until now. Herein, we demonstrate that T. spiralis, a parasite that lacks the ability to synthesize heme autonomously, has evolved a sophisticated mechanism to scavenge and utilize heme from its host. By employing an aspartic protease to degrade host hemoglobin and myoglobin in the parasitic niche, T. spiralis is able to liberate heme for its own growth and survival. The structurally and functionally conserved Ts-HRG-1 protein plays a key role in transporting heme to the entire worm, particularly to functional organs, such as the cuticle and stichosome. More importantly, we discovered that the interaction between Ts-HRG-1 and Ts-ATP6V0C results in the formation of a functional complex that is essential for the parasite's heme acquisition. The intervention effect achieved by Ts-ATP6V0C RNAi or inhibiting the activity of Ts-ATP6V0C with bafilomycin A1 (BafA1) was consistent with Ts-HRG-1 RNAi, resulting in impaired heme uptake, developmental arrest and a reduced larval burden in mouse hosts. These findings enhance our understanding of the parasite's heme acquisition mechanism and identify the development of drugs that target proteins that interact with HRG-1 as a new direction in anthelminthic drug research.

#2

Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy.

International journal of molecular sciences2026 Mar 07

Hepatic encephalopathy is a severe complication of liver failure, traditionally investigated through brain-liver interactions; however, the involvement of extrahepatic organs remains poorly understood. This study examined splenic histopathological changes in a mouse model of acute hepatic encephalopathy induced by ammonium acetate administration, focusing on iron metabolism and macrophage activation. Although conventional hematoxylin and eosin staining revealed no overt structural abnormalities, unstained spleen sections demonstrated abundant black deposits, predominantly in the red pulp. Prussian blue staining confirmed a significant increase in hemosiderin-positive cells; however, a subset of black deposits was iron-negative. Immunohistochemical analyses revealed that these iron-negative pigments were localized within F4/80-positive macrophages and colocalized with heme oxygenase-1 (HO-1), suggesting enhanced heme degradation. Ultrastructural observations further identified electron-dense granules consistent with hematin accumulation in splenic macrophages. Hematological analyses revealed significant reductions in red blood cell count and hemoglobin levels, indicating accelerated erythrocyte destruction. Collectively, these findings demonstrate that acute hepatic encephalopathy induces splenic macrophage activation, accompanied by disordered iron metabolism and hematin accumulation. This study highlights the spleen as a previously underappreciated extrahepatic organ involved in the pathophysiology of hepatic encephalopathy and suggests that splenic heme-iron handling may represent a novel therapeutic target.

#3

Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.

Proceedings of the National Academy of Sciences of the United States of America2026 Mar 10

Hemolysis is associated with the release of damage-associated molecular patterns, including free heme and extracellular DNA (ecDNA). Using several mouse models of bleeding anemia and hemolysis, we demonstrate a significant increase in plasma ecDNA, independent of neutrophil extracellular trap formation. This ecDNA forms G-quadruplex (G4) structures, which we detected in both mice and patients with systemic lupus erythematosus. Catalytic complexes (DNAzymes) formed by G4 ecDNA and heme drive oxidative stress, tissue injury, and inflammation. In anemic mice lacking deoxyribonuclease 1L3 (DNase1l3-/-), we found elevated polynucleosomal ecDNA in the plasma, reduced expression of the heme-degrading enzyme heme oxygenase-1 in macrophages, but also increased plasma creatinine, renal iron accumulation, and complement C3 deposition along elevated apoptosis and DNA damage. ecDNA isolated from these mice also triggered toll-like receptor 9-dependent inflammatory responses in vitro and in vivo. In summary, these findings suggest that concurrent release of heme and ecDNA during hemolysis promotes inflammation and tissue damage, contributing to lupus pathogenesis.

#4

Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis.

PLoS pathogens2026 Feb

Leishmania spp. are intracellular parasites that cause leishmaniasis, a devastating disease with no effective treatment. These parasites are heme auxotrophs and must scavenge this essential cofactor from the host. Transcriptomic analysis of Leishmania major promastigotes cultured in the presence or absence of heme revealed numerous differentially expressed genes. Among those of unknown function, LHR2 (Leishmania Heme Response-2) was the most upregulated gene in response to heme limitation. LHR2 encodes a mitochondrial hemoprotein that likely protects this organelle from elevated levels of reactive oxygen species. It is essential during the promastigote stage, and loss of a single LHR2 allele severely compromises intracellular replication and prevents the development of cutaneous leishmaniasis in mice. This essential function depends on LHR2's ability to bind heme. Complementation studies in Saccharomyces cerevisiae revealed that LHR2 is an analogue of the yeast Dap1p, although it binds heme in a distinct manner. Importantly, LHR2 displays key structural differences from the most closely related human proteins. These findings highlight LHR2 as a critical factor in parasite survival and pathogenesis, and suggest it as a promising new target for antileishmanial drug development.

#5

Nutrigenomic profiling identifies ZIP10 (SLC39A10) as a regulator of erythroid zinc homeostasis with genetic associations to anemia risk.

Proceedings of the National Academy of Sciences of the United States of America2026 Feb 24

Erythroid progenitors undergo dynamic morphological changes and robust heme biosynthesis during differentiation. Zinc is essential for erythropoiesis, yet the mechanisms linking zinc availability to heme biosynthesis and anemia risk remain unclear. This study aimed to define zinc-responsive pathways in differentiating erythroid progenitors and to evaluate the translational relevance of SLC39A10 (ZIP10) genetic variants to hematological health. To elucidate the molecular basis of zinc's role in erythropoiesis, we performed transcriptomic profiling of zinc-restricted G1E-ER4 cells during differentiation and compared it to iron chelation and δ-aminolevulinic acid dehydratase inhibition. Zinc deficiency uniquely enriched genes involved in not only heme biosynthesis but cellular maintenance functions. Zinc restriction caused a marked suppression of Alad transcript abundance, impairing the first enzymatic step of cytosolic heme biosynthesis. Notably, Slc39a10 (Zip10) was the only zinc transporter strongly induced by zinc deficiency, independent of iron status. Loss of ZIP10 exacerbated zinc depletion, further reduced Alad expression, and diminished heme output, highlighting its role as a compensatory importer during zinc scarcity. GWAS database analyses revealed that SLC39A10 variants are significantly associated with hemoglobin concentration, hematocrit, and iron deficiency anemia risk. Together, ZIP10 safeguards erythroid zinc homeostasis and heme synthesis under limiting zinc conditions. Genetic variation in SLC39A10 may heighten sensitivity to zinc deficiency, providing a potential nutrigenetic marker for anemia risk. These findings establish a mechanistic and translational basis for genotype-guided precision nutrition strategies to improve hematological health.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Cysteine desulfurase protects against intracerebral hemorrhage by inhibiting neuronal ferroptosis through the suppression of iron-responsive element-binding protein 2-mediated iron-starvation responses.

Neuroreport
2026

4-Aminoquinolines block heme iron reactivity and interfere with artemisinin action.

eLife
2026

Clinical Practice Guidelines for the Management of Porphyrias in Japan: Secondary Publication (English Translation).

The Journal of dermatology
2026

Bafilomycin A1 is a promising therapeutic agent against T. spiralis infection by inhibiting the heme-transporting ATP6V0C/HRG-1 complex.

PLoS pathogens
2026

Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy.

International journal of molecular sciences
2026

Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.

Proceedings of the National Academy of Sciences of the United States of America
2026

Colouring dysbiosis: FetB-dependent Mn-PPIX produced by Porphyromonas gingivalis shapes the oral microbiota.

NPJ biofilms and microbiomes
2026

Murine Biocompatibility Evaluation of an Albumin-Derived Complex and Nanoparticle Delivery System for Ocular Applications.

Journal of biomedical materials research. Part A
2026

Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis.

PLoS pathogens
2026

Management of porphyria-like syndrome in tyrosinemia type 1.

Journal of pediatric endocrinology & metabolism : JPEM
2026

Hyponatremia and Abdominal Pain: A Case Report of Acute Hepatic Porphyria.

Cureus
2026

Nutrigenomic profiling identifies ZIP10 (SLC39A10) as a regulator of erythroid zinc homeostasis with genetic associations to anemia risk.

Proceedings of the National Academy of Sciences of the United States of America
2026

Aminolevulinate inhibition of human coproporphyrinogen oxidase clarifies coproporphyrin III accumulation in porphyrias.

Bioscience reports
2026

HO-1/Nrf2 activation orchestrates protection in sepsis-induced lung injury by suppressing CCR2hi monocyte recruitment and MAPK-driven inflammation.

Free radical biology & medicine
2026

In vitro activity of gallium-protoporphyrin IX against Leishmania major and Leishmania infantum.

Microbiology spectrum
2026

SIADH as an Underrecognized Manifestation of Porphyria-like Crises in Hereditary Tyrosinemia Type 1: Clinical and Pathophysiological Insights.

International journal of molecular sciences
2026

Dysregulated iron metabolism associates with neutrophilic airway inflammation in COPD.

Clinical science (London, England : 1979)
2026

Genetic traits and diet triggering the iron-induced hepatic model of the idiopathic disorder sporadic porphyria cutanea tarda.

Free radical biology & medicine
2026

Disruption of intracellular iron homeostasis through mitochondrial dysfunction associated with suppression of ATP 13A2 expression.

Scientific reports
2026

Human neuroglobin and H64A distal variant: How mutation and pH affect the heme pocket.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
2026

Cross-species evaluation of TANGO2 homologs, including HRG-9 and HRG-10 in Caenorhabditis elegans, challenges a proposed role in heme trafficking.

eLife
2025

Involvement of HemI, an ECF sigma factor, in hemin acquisition and antibiotic susceptibility in Stenotrophomonas maltophilia.

Frontiers in cellular and infection microbiology
2026

Rothia mucilaginosa membrane vesicles stabilize labile iron to alleviate UVB-induced ferroptosis.

Cell host & microbe
2026

Liver sinusoidal endothelial cells constitute a major route for hemoglobin clearance.

EMBO reports
2025

TMAO converts cytochrome c into a pro-apoptotic peroxidase by destabilizing the heme-Met80 ligation.

Cellular and molecular biology (Noisy-le-Grand, France)
2025

Whole transcriptome analysis reveals T cell signaling activation in septic patients with thrombocytopenia.

Scientific reports
2026

A reversible feedback mechanism regulating mitochondrial heme synthesis.

The Journal of biological chemistry
2025

Monocyte-red blood cell crosstalk supports clearance and heme metabolism in sickle cell anemia.

Frontiers in immunology
2025

Heme drives cardiac endothelial senescence in sepsis via STING activation.

Cell death & disease
2026

Epithelial HO-1 regulates iron availability and promotes colonic tumorigenesis in a context-dependent manner.

JCI insight
2026

Quantification and diagnostic relevance of blood and heme-mediated inhibition of prion detection by RT-QuIC.

Journal of clinical microbiology
2026

Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial.

Journal of the American Academy of Dermatology
2025

Psychiatric Presentation of Hereditary Coproporphyria with Coproporphyrinogen Oxidase Gene Mutation c.734 C>T: A Case Report.

Noro psikiyatri arsivi
2025

Rapid mitochondrial repolarization upon reperfusion after cardiac ischemia.

Nature cardiovascular research
2026

Liver Transplantation and Other Hepatically Directed Therapies Do Not Change the Biochemical Phenotype nor Halt Progression of Leukodystrophy due to Biallelic HMBS Variants: A Case Report.

JIMD reports
2026

The heme A synthase Cox15, as a target of redox-active 3-benzylmenadiones with antiparasitic activity.

Antimicrobial agents and chemotherapy
2025

Multitarget inhibitory effects of lemongrass essential oil on Porphyromonas gingivalis: synergistic regulation of heme utilization, biofilm formation, and the metabolic pathway of ferroptosis.

BMC complementary medicine and therapies
2025

Recent Advances in Bio-Based Production of Free Heme Using Microbial Metabolic Engineering.

Advanced biology
2025

Targeting HMGB1 in endothelial cells reverses heme-induced SIRS after radiofrequency ablation of hepatic hemangioma.

Frontiers in immunology
2026

Comprehensive analysis of complement activation in a hydroxyurea-treated patient cohort with sickle cell disease.

Blood advances
2026

Crosstalk between Nitric Oxide and Bioinorganic Centers: Implications for Cellular Signaling.

Chemical record (New York, N.Y.)
2026

Enhancing the aqueous solubility of hemin at physiological pH through encapsulation within polyvinylpyrrolidone nanofibres.

International journal of pharmaceutics
2025

Porphyrias: Pathophysiology and clinical management recommendations for hepatologists.

Hepatology communications
2025

Heme processing in the malaria parasite, Plasmodium falciparum: a time-dependent basal-level analysis.

Communications biology
2025

Urinary Porphyrin Profiles and Trace Element Imbalances in Children with Autism Spectrum Disorders: Insights into Environmental and Metabolic Biomarkers.

International journal of molecular sciences
2025

Conformational constraints and ligand interactions are key determinants of the distinct aggregation pathways observed in human serum albumin.

International journal of biological macromolecules
2026

A Dynamic Gate Enables Regioselective Hydroxylation of Free Arginine by a Non-Canonical Heme Enzyme.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Investigating Electron Conductivity Regimes in the Bacterial Cytochrome Wire OmcS.

The journal of physical chemistry. B
2026

Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria.

Blood advances
2025

Heme Trafficking and the Importance of Handling Nature's Most Versatile Cofactor.

Chemical reviews
2025

Pathogenesis and clinical management of liver damage in porphyrias: Mechanisms and therapeutic approaches.

World journal of hepatology
2025

Nitric oxide regulates cytochrome P450 2D6 and 3A4 activity via concentration-dependent modulation of heme loading.

The Journal of biological chemistry
2025

A ratiometric fluorescent probe for the specific detection of carbon monoxide released from CORM-3 and induced by heme in living cells.

Analytica chimica acta
2025

Zinc protoporphyrin-triggered ferroptosis plays a critical role in renal proximal tubular cell damage and chronic kidney disease.

Life sciences
2025

Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Chemical Society reviews
2025

Altered Heme and Redox Homeostasis Underpin Late-onset Alzheimer's Disease.

International journal of biological sciences
2025

Blocking extracellular glycine uptake mediated by GlyT1 mitigates protoporphyria.

The Journal of clinical investigation
2025

Ascorbate mitigates oxidative stress and hemin cytotoxicity in heme oxygenase-1 deficiency.

The Journal of biological chemistry
2025

Molecular Insights into the Pathophysiology of Dysregulated Erythropoiesis: The Crucial Role of Iron Homeostasis.

Molecular and cellular biology
2025

Caspase-1 activation drives vascular inflammatory processes and hypoperfusion in intravascular hemolysis.

American journal of physiology. Heart and circulatory physiology
2025

Silencing of METTL14 attenuates experimental intracerebral hemorrhage by suppressing TFRC-mediated ferroptosis.

Brain research
2025

Structural basis of heme scavenging by the ChtA and HtaA hemophores in Corynebacterium diphtheriae.

The Journal of biological chemistry
2025

Animal Models of Porphyria with Hepatic Involvement.

Seminars in liver disease
2025

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.

Arteriosclerosis, thrombosis, and vascular biology
2025

Hemopexin and HO-1 induction during acute colitis in mice is dependent on interleukin-22.

Frontiers in immunology
2025

How Sodium Dodecyl Sulfate Micelles Affect the Coordination and Peroxidase-Like Activity of the Hemin-Aβ16 Complex.

ChemPlusChem
2025

Peroxynitrite detoxification by Trypanosoma cruzi heme peroxidase supports parasite survival in macrophages.

The Journal of biological chemistry
2025

Podocyte dysfunction driven by heme in sickle-cell nephropathy.

Scientific reports
2025

Dual role of Heme oxygenase-1 in disease progression and treatment: A literature review.

International journal of biological macromolecules
2025

Renewable DNA tetrahedron Interface enabling ultrasensitive detection of copper via synergetic enhancement of click chemistry and DNAzyme catalysis.

Bioelectrochemistry (Amsterdam, Netherlands)
2025

The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria.

The Journal of clinical investigation
2025

Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradation.

JCI insight
2025

Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia.

Scientific reports
2025

Evidence for alcohol-mediated hemolysis and erythrophagocytosis.

Redox biology
2025

Comparative effectiveness of human hematin and heme arginate in the management of porphyria attacks: an observational study across three hospitals in Colombia.

Hospital practice (1995)
2025

Stress-induced heme metabolic disorder in peripheral B cells contributes to depressive-like behaviors in male mice.

Progress in neurobiology
2025

Development of rat and mouse models of heme-iron absorption.

JCI insight
2025

Nrf2-HO1 signaling pathway-mediated axial elongation in lens-induced myopia in Guinea pigs through regulation of tight junctions in retinal pigment epithelial cells.

Experimental eye research
2025

NADPH oxidase-dependent heme oxygenase-1 expression mediates cigarette smoke-induced ferroptosis via intracellular Fe(II) accumulation.

Free radical biology & medicine
2025

Exploiting haem-iron dependence of nontypeable Haemophilus influenzae: an avenue for future therapeutic development.

Frontiers in cellular and infection microbiology
2025

HmuY proteins of the Porphyromonas genus show diversity in heme-binding properties.

Frontiers in cellular and infection microbiology
2025

FapR regulates HssRS-mediated heme homeostasis in Bacillus anthracis.

mBio
2026

Role of biliverdin reductase, a heme degradation pathway enzyme, in the development of vasospasm after subarachnoid hemorrhage.

Journal of neurointerventional surgery
2025

Zinc protoporphyrin accumulation as a positive regulator of renal heme oxygenase-1 participates in the progression of chronic kidney disease.

Biochemical and biophysical research communications
2025

Cyclodextrin-Assisted l-Cysteine-Capped Copper Nanoclusters: Rapid Synthesis, Enhanced Photoluminescence, and Small Molecule Interactions in Complex Biological Matrices.

Chemistry, an Asian journal
2025

HCAR2 is a novel receptor for heme.

Blood advances
2025

Computing pathogenicity of mutations in human cytochrome P450 superfamily.

Biochimica et biophysica acta. Proteins and proteomics
2025

Exploring heme and iron acquisition strategies of Porphyromonas gingivalis-current facts and hypotheses.

FEMS microbiology reviews
2025

Efficacy and safety of givosiran in Japanese patients with acute hepatic porphyria: clinical findings from an expanded access study.

Scientific reports
2025

Ambient fine particulate matter induces cardiac fibrosis through triggering ferroptosis by heme degradation induced-iron overload.

Ecotoxicology and environmental safety
2025

The interplay between the myeloperoxidase-hypochlorous acid system, heme oxygenase, and free iron in inflammatory diseases.

Journal of inorganic biochemistry
2025

Hemin-induced transient senescence via DNA damage response: a neuroprotective mechanism against ferroptosis in intracerebral hemorrhage.

Communications biology
2025

Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice.

International journal of molecular sciences
2025

The heme scavenger hemopexin protects against lung injury during aspergillosis by mitigating release of neutrophil extracellular traps.

JCI insight
2025

Reactive astrocyte-derived exosomes enhance intracranial lymphatic drainage in mice after intracranial hemorrhage.

Fluids and barriers of the CNS
2025

Understanding Coproporphyrins and Their Disposition: Coproporphyrinuria is Common, of Diverse Cause, and Rarely Indicates Porphyria.

The American journal of medicine
2025

A Narrowband 635 nm Autofluorescence Peak in Albino Mouse Eyes Found With Multi-Modal Imaging Reveals the Presence of Protoporphyrin IX in the Choroid.

Investigative ophthalmology & visual science
2025

The role of heme in sepsis induced Kupffer cell PANoptosis and senescence.

Cell death & disease
2025

Characterization of a heme-degrading enzyme that mediates fitness and pathogenicity in Enterococcus faecalis.

mBio
2025

Heme-Aβ compound 0: a common intermediate in ROS generation and peroxidase activity.

Dalton transactions (Cambridge, England : 2003)
2025

Unmasked acute intermittent porphyria in a patient with COVID-19-associated posterior reversible encephalopathy syndrome.

BMC neurology
2025

Heme-induced lung injury in human precision cut lung slices: a new model for acute lung injury.

Respiratory research
2026

Impact of NH4+ on the catalytic activity of G-quadruplex/hemin DNAzyme for chemiluminescent sensing.

Analytical and bioanalytical chemistry
2025

Self-contained G-quadruplex/hemin DNAzyme: a superior ready-made catalyst for in situ imaging analysis.

Nucleic acids research
2025

A high-sensitivity label-free electrochemical aptasensor for point-of-care measurements of low-density lipoprotein in plasma based on aptamer and MXene-CMCS-Hemin nanocomposites.

Bioelectrochemistry (Amsterdam, Netherlands)
2025

Molecular dynamics, docking and quantum calculations reveal conformational changes influenced by CYP271A amino acid mutations related to cerebrotendinous xanthomatosis.

Scientific reports
2025

ACE2 deficiency protects against heme protein-induced acute kidney injury.

American journal of physiology. Renal physiology
2025

Multiple classes of human intracellular Heme-binding proteins with pathology-associated polymorphisms of heme coordinating residues.

Biochimica et biophysica acta. Molecular basis of disease
2025

The Pseudomonas aeruginosa PhuS proximal ligand His-209 triggers a conformational switch in function from DNA binding to heme transfer.

The Journal of biological chemistry
2025

Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylation.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Kidney-targeting DNA tetrahedral molecular cage synergistically inhibits acute kidney injury by clearing ROS and activating HO-1.

Biomaterials
2025

Practical Recommendations in the Treatment of Acute and Chronic Life-Threatening Infectious Diseases in Patients with Acute Hepatic Porphyria.

Metabolites
2025

Analysis of Ferric Protoporphyrin IX Effects on Human Platelets: Hematin Is a More Potent Agonist than Hemin.

Cells
2025

Heme and immunity: The heme oxygenase dichotomy.

Journal of inorganic biochemistry
2025

On-Origami Molecular Crowding Control of G-Quadruplex DNAzymes.

Small methods
2025

ROCK1 promotes B cell differentiation and proteostasis under stress through the heme-regulated proteins, BACH2 and HRI.

JCI insight
2025

Structural Basis and Mechanism of a Unique Haemophore in the Haem-Iron Acquisition by Riemerella anatipestifer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Targeting lung heme iron by aerosol hemopexin adminstration in sickle cell disease pulmonary hypertension.

Free radical biology & medicine
2025

Transcriptomic atlas reveals organ-specific disease tolerance in sickle cell mice.

Blood advances
2025

The Histamine Pathway is a Target to Treat Hepatic Experimental Erythropoietic Protoporphyria.

Cellular and molecular gastroenterology and hepatology
2025

Detection of microRNA-21 based on smartly designed ratiometric electrochemical sensor and dual-signal amplification.

Analytica chimica acta
2025

Transsulfuration pathway activation attenuates oxidative stress and ferroptosis in sickle primary erythroblasts and transgenic mice.

Communications biology
2025

Molecular basis of hemoglobin binding and heme removal in Corynebacterium diphtheriae.

Proceedings of the National Academy of Sciences of the United States of America
2024

Acute Intermittent Porphyria in an Adolescent Patient: Diagnostic and Treatment Challenges.

Cureus
2024

A Porcine-Derived Heme Iron Powder Restores Hemoglobin in Anemic Rats.

Nutrients
2024

Malaria parasites require a divergent heme oxygenase for apicoplast gene expression and biogenesis.

eLife
2025

Structural insights into the role of NahX from Pseudomonas sp. MC1 in the naphthalene degradation pathway.

Biochemical and biophysical research communications
2024

Porphyria cutanea tarda: a unique iron-related disorder.

Hematology. American Society of Hematology. Education Program
2024

Nonheme iron catalyst mimics heme-dependent haloperoxidase for efficient bromination and oxidation.

Science advances
2024

Respiratory complex II acting as a homeostatic regulatory sensor.

Physical chemistry chemical physics : PCCP
2024

Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology.

Frontiers in immunology
2024

Blood matters: the hematological signatures of Coronavirus infection.

Cell death & disease
2025

Hemin, copper and amyloid-β: A medley involved in Alzheimer's disease. An interaction that fine regulates the reactivity.

Journal of inorganic biochemistry
2024

SP1-mediated SYN1 promotes hemin-induced damage in PC12 cells in vitro and exacerbates blood-barrier disruption and brain injury after intracerebral hemorrhage in vivo.

Pathology, research and practice
2024

Capturing ultrafast energy flow of a heme protein in crowded milieu.

Physical chemistry chemical physics : PCCP
2024

A glutamine metabolic switch supports erythropoiesis.

Science (New York, N.Y.)
2025

Ginsenoside Rb1 targets to HO-1 to improve sepsis by inhibiting ferroptosis.

Free radical biology & medicine
2025

Exosomes from polarized Microglia: Proteomic insights into potential mechanisms affecting intracerebral hemorrhage.

Gene
2024

Herbicides as fungicides: Targeting heme biosynthesis in the maize pathogen Ustilago maydis.

Molecular plant pathology
2024

SARS-CoV-2 variants induce increased inflammatory gene expression but reduced interferon responses and heme synthesis as compared with wild type strains.

Scientific reports
2024

Counteraction of unconjugated bilirubin against heme-induced toxicity in platelets.

Thrombosis research
2024

Protoporphyrin IX-Dependent Antiviral Effects of 5-Aminolevulinic Acid against Feline Coronavirus Type II.

Viruses
2024

Nox4 is involved in acute kidney injury associated to intravascular hemolysis.

Free radical biology & medicine
2024

AZD8055 Is More Effective Than Rapamycin in Inhibiting Proliferation and Promoting Mitochondrial Clearance in Erythroid Differentiation.

Analytical cellular pathology (Amsterdam)
2025

Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates.

Gut
2024

Melatonin alleviates heme-induced ferroptosis via activating the Nrf2/HO-1 pathway in neurons.

European review for medical and pharmacological sciences
2024

[Pathophysiology of sideroblastic anemia].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2024

TMEM56 deficiency impairs the haem metabolism and cell cycle progression during human erythropoiesis.

British journal of haematology
2024

Therapeutic approach to acute crises of hepatic porphyrias.

Revista clinica espanola
2024

The Role of Heme Oxygenase 1 in Rheumatoid Arthritis and IL-1 Induced Inflammatory Cell Model.

Annals of clinical and laboratory science
2024

Heme: A link between hemorrhage and retinopathy of prematurity progression.

Redox biology
2024

Evaluation of the potential use of protoporphyrins as biomarkers of anemic disease in human urine from inflammatory bowel disease patients.

Journal of pharmaceutical and biomedical analysis
2024

Harnessing Porphyrin Accumulation in Liver Cancer: Combining Genomic Data and Drug Targeting.

Biomolecules
2024

PpIX-enabled fluorescence-based detection and photodynamic priming of platinum-resistant ovarian cancer cells under fluid shear stress.

Photochemistry and photobiology
2024

Inhibition of Heme Oxygenase 1 Suppresses Growth, Migration, and Invasion, and Regulates Tumor-Infiltrating CD8+ T Cells and in Uveal Melanoma.

Investigative ophthalmology & visual science
2024

A novel electrochemical aptasensor based on NrGO-H-Mn3O4 NPs integrated CRISPR/Cas12a system for ultrasensitive low-density lipoprotein determination.

Mikrochimica acta
2024

Longitudinal transcriptomic analysis reveals persistent enrichment of iron homeostasis and erythrocyte function pathways in severe COVID-19 ARDS.

Frontiers in immunology
2024

Integration of epidemiological and blood biomarker analysis links haem iron intake to increased type 2 diabetes risk.

Nature metabolism
2024

Resonance Raman spectral analysis of the heme site structure of cytochrome c oxidase with its positive regulator CHCHD2.

Journal of inorganic biochemistry
2024

Hemin regulates platelet clearance in hemolytic disease by binding to GPIbα.

Platelets
2024

Heme- and iron-activated macrophages in sickle cell disease: an updated perspective.

Current opinion in hematology
2025

Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.

Liver international : official journal of the International Association for the Study of the Liver
2024

Fluorometric Methods to Measure Bioavailable and Total Heme.

Methods in molecular biology (Clifton, N.J.)
2024

Canadian guidance for diagnosis and management of acute hepatic porphyrias.

Clinical biochemistry
2024

Nitrite exposure leads to glycolipid metabolic disorder via the heme-HO pathway in teleost.

Ecotoxicology and environmental safety
2025

Practical recommendations for biochemical and genetic diagnosis of the porphyrias.

Liver international : official journal of the International Association for the Study of the Liver
2024

Microfluidic synthesis of hemin@ZIF-8 nanozyme with applications in cellular reactive oxygen species detection and anticancer drug screening.

Lab on a chip
2024

Impact of Phosphorylation at Various Sites on the Active Pocket of Human Ferrochelatase: Insights from Molecular Dynamics Simulations.

International journal of molecular sciences
2024

[An overview of porphyrias].

Dermatologie (Heidelberg, Germany)
2024

Cysteine in the R3 Tau Peptide Modulates Hemin Binding and Reactivity.

Inorganic chemistry
2024

Erythropoietic protoporphyrias: updates and advances.

Trends in molecular medicine
2024

Elucidating the Role of Human ALAS2 C-terminal Mutations Resulting in Loss of Function and Disease.

Biochemistry
2024

Heme-induced loss of renovascular endothelial protein C receptor promotes chronic kidney disease in sickle mice.

Blood
2024

Exploring current and emerging therapies for porphyrias.

Liver international : official journal of the International Association for the Study of the Liver
2024

Export of heme by the feline leukemia virus C receptor regulates mitochondrial biogenesis and redox balance in the hematophagous insect Rhodnius prolixus.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2024

A Haemophilus ducreyi strain lacking the yfeABCD iron transport system is virulent in human volunteers.

Infection and immunity
2024

From chemistry to genomics: A concise history of the porphyrias.

Liver international : official journal of the International Association for the Study of the Liver
2024

GPR30 alleviated subarachnoid hemorrhage-induced blood-brain barrier dysfunction by activating the PI3K/Akt and Nrf2/HO-1 pathways.

American journal of physiology. Cell physiology
2024

Causal effects of genetically determined metabolites on androgenetic alopecia: A two-sample Mendelian randomization analysis.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
2024

TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia.

Nature communications
2024

Congenital erythropoietic porphyria.

Liver international : official journal of the International Association for the Study of the Liver
2024

Hemoglobin scavenger receptor CD163 as a potential biomarker of hemolysis-induced hepatobiliary injury in sickle cell disease.

American journal of physiology. Cell physiology
2024

Dietary Hemin Remodels Gut Microbiota and Mediates Tissue Inflammation and Injury in the Small Intestine.

Molecular nutrition & food research
2024

Hydroxychloroquine inhibits hemolysis-induced arterial thrombosis ex vivo and improves lung perfusion in hemin-treated mice.

Journal of thrombosis and haemostasis : JTH
2024

Label-free and portable detection of HIV-DNA by a handheld luminometer.

Analytica chimica acta
2024

Stability of porphyrins and porphyrin precursors in urine and plasma samples: implications for sample handling and storage.

Journal of clinical pathology
2024

In-depth structure-function profiling of the complex formation between clotting factor VIII and heme.

Thrombosis research
2025

Case-based discussion of the acute hepatic porphyrias: Updates on pathogenesis, diagnosis and management.

Liver international : official journal of the International Association for the Study of the Liver
2025

Acute hepatic porphyrias-A guide for hepatologists.

Hepatology (Baltimore, Md.)
2024

HemU and TonB1 contribute to hemin acquisition in Stenotrophomonas maltophilia.

Frontiers in cellular and infection microbiology
2024

CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer.

Molecular therapy. Oncology
2024

The clinical relevance of heme detoxification by the macrophage heme oxygenase system.

Frontiers in immunology
2025

Computational identification of potential modulators of heme-regulated inhibitor (HRI) for pharmacological intervention against sickle cell disease.

Journal of biomolecular structure & dynamics
2024

The Digestive Vacuole of the Malaria Parasite: A Specialized Lysosome.

Pathogens (Basel, Switzerland)
2024

Hematin- and Hemin-Induced Spherization and Hemolysis of Human Erythrocytes Are Independent of Extracellular Calcium Concentration.

Cells
2025

Liver transplantation and primary liver cancer in porphyria.

Liver international : official journal of the International Association for the Study of the Liver
2024

Toxoplasma gondii harbors a hypoxia-responsive coproporphyrinogen dehydrogenase-like protein.

mSphere
2024

Pivotal Role of GSTO2 in Ferroptotic Neuronal Injury After Intracerebral Hemorrhage.

Journal of molecular neuroscience : MN
2024

Functional characterization of RhuB as a second TonB2-dependent hemin receptor in Riemerella anatipestifer CH-1.

Microbiology spectrum

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Alteração do metabolismo da porfirina e do heme.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Alteração do metabolismo da porfirina e do heme

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Bafilomycin A1 is a promising therapeutic agent against T. spiralis infection by inhibiting the heme-transporting ATP6V0C/HRG-1 complex.
    PLoS pathogens· 2026· PMID 41838682mais citado
  2. Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy.
    International journal of molecular sciences· 2026· PMID 41828682mais citado
  3. Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.
    Proceedings of the National Academy of Sciences of the United States of America· 2026· PMID 41779796mais citado
  4. Heme limitation induces LHR2, an essential gene for Leishmania pathogenesis.
    PLoS pathogens· 2026· PMID 41739884mais citado
  5. Nutrigenomic profiling identifies ZIP10 (SLC39A10) as a regulator of erythroid zinc homeostasis with genetic associations to anemia risk.
    Proceedings of the National Academy of Sciences of the United States of America· 2026· PMID 41701827mais citado
  6. Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1.
    Orphanet J Rare Dis· 2026· PMID 41987183recente
  7. Real-time breath metabolomics as catalyst for personalized lung cancer diagnostics: prospective matched case-control trial (LUCAbreath).
    Transl Lung Cancer Res· 2026· PMID 41982695recente
  8. The mutational burden in os odontoideum patients.
    Orphanet J Rare Dis· 2026· PMID 41981692recente
  9. European Reference Networks - a flagship activity of the EU in the field of rare and complex diseases: from 2017 to 2025.
    Orphanet J Rare Dis· 2026· PMID 41981625recente
  10. Clinical characteristics and long-term prognosis of anti-MDA5-positive dermatomyositis: a comparative study across age groups.
    Orphanet J Rare Dis· 2026· PMID 41965859recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309813(Orphanet)
  2. MONDO:0017754(MONDO)
  3. GARD:21346(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55787330(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Alteração do metabolismo da porfirina e do heme
Compêndio · Raras BR

Alteração do metabolismo da porfirina e do heme

ORPHA:309813 · MONDO:0017754
Medicamentos
7 registrados
MedGen
Wikidata
Evidência
🥉 Relato de caso
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades